This inventor holds 11 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Bergenbio Asa, Novartis Ag. Active years: 1997-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nottingham, GB (1997 - 2020)
- Southwell, GB (2018 - 2024)
Company Filing History:
3 out of 846 
2 out of 13 
2 out of 3,978 
Years Active: 1997-2026
Title: The Innovations of John Paul Watts
Introduction
John Paul Watts is a notable inventor based in Southwell, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific protein kinases. With a total of 10 patents to his name, Watts has established himself as a key figure in the pharmaceutical industry.
Latest Patents
Among his latest innovations are the benzolactam compounds that serve as protein kinase inhibitors. These compounds are designed to inhibit ERK1/2 kinases, which play a crucial role in various cellular processes. The therapeutic potential of these compounds lies in their application for treating ERK1/2-mediated conditions, particularly cancer. The invention provides a compound of formula (0), which has shown promise in the treatment of this devastating disease.
Career Highlights
Watts has had a distinguished career, working with prominent companies such as Otsuka Pharmaceutical Company and Novartis AG. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Stuart Thomas Onions and Alan Naylor. Their collective expertise has undoubtedly enhanced the quality and impact of the projects they have undertaken together.
Conclusion
John Paul Watts continues to be a driving force in the field of medicinal chemistry, with his innovative patents paving the way for new therapeutic options in cancer treatment. His contributions are invaluable to the ongoing fight against this disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile